Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FGFR3 |
| Variant | G382D |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | FGFR3 G382D lies within the transmembrane domain of the Fgfr3 protein (UniProt.org). G382D is not transforming (PMID: 11429702), results in decreased chondrocyte autophagy and proliferation and decreased skeletal development in mice but increased Erk phosphorylation, Lc3a and p62 expression, mitonchondrial fission, and cuproptosis in culture (PMID: 39991457), and constitutive activation of Fgfr3 and downstream signaling in culture (PMID: 11429702), and therefore, is predicted to lead to a gain of Fgfr3 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
FGFR3 mutant FGFR3 act mut FGFR3 G382D |
| Transcript | NM_000142.5 |
| gDNA | chr4:g.1804399G>A |
| cDNA | c.1145G>A |
| Protein | p.G382D |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_006713873.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513422 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513420.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713869 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713868 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513420 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713871.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713870 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713869.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713870.2 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| NM_000142 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001163213.2 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713869.2 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001354809.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_047449820.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_047449821.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513422.2 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| NM_000142.5 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001354809.2 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001163213 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513420.2 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713873.2 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713873 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713872 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_011513422.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| NM_000142.4 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713868.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_047449823.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_047449824.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713871.2 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713871 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001354810.2 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713870.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001163213.1 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| NM_001354810.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| XM_006713868.2 | chr4:g.1804393_1804394delGGinsAC | c.1145_1146delGGinsAC | p.G382D | RefSeq | GRCh38/hg38 |
| XM_047449822.1 | chr4:g.1804399G>A | c.1145G>A | p.G382D | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|